Serina Therapeutics (SER) Times Interest Earned (2021 - 2025)

Serina Therapeutics (SER) has disclosed Times Interest Earned for 5 consecutive years, with -$31.35 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned rose 90.4% to -$31.35 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$112.78 through Dec 2025, down 247.97% year-over-year, with the annual reading at -$112.78 for FY2025, 247.97% down from the prior year.
  • Times Interest Earned hit -$31.35 in Q4 2025 for Serina Therapeutics, up from -$1065.3 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $1.37 in Q4 2023 to a low of -$1065.3 in Q3 2025.
  • Historically, Times Interest Earned has averaged -$144.28 across 5 years, with a median of -$11.19 in 2023.
  • Biggest five-year swings in Times Interest Earned: soared 175.15% in 2023 and later tumbled 23937.54% in 2024.
  • Year by year, Times Interest Earned stood at -$6.33 in 2021, then soared by 71.21% to -$1.82 in 2022, then skyrocketed by 175.15% to $1.37 in 2023, then crashed by 23937.54% to -$326.41 in 2024, then surged by 90.4% to -$31.35 in 2025.
  • Business Quant data shows Times Interest Earned for SER at -$31.35 in Q4 2025, -$1065.3 in Q3 2025, and -$618.33 in Q2 2025.